Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
American Journal of Translational Research|January 26, 2016
Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirinMichele Malaguarnera, Massimo Motta, Marco Vacante, et al.
Hepatitis Monthly|November 17, 2011
Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patientsMichele Malaguarnera, Marco Vacante, Cristina Russo, et al.
BMC Psychiatry|November 16, 2016
Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work abilityGiulia Malaguarnera, Gaetano Bertino, Giuseppe Chisari, et al.
Biomed Research International|May 31, 2014
Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathyGiulia Malaguarnera, Caterina Gagliano, Maria Giordano, et al.
Hepatitis Monthly|June 10, 2014
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical TrialGiulia Malaguarnera, Manuela Pennisi, Caterina Gagliano, et al.
Frontiers in Endocrinology|May 10, 2019
Hypothyroidism as a Predictor of Surgical Outcomes in the ElderlyMarco Vacante, Antonio Biondi, Francesco Basile, et al.
Biomed Research International|November 28, 2013
Carbohydrate 19.9 antigen serum levels in liver diseaseGaetano Bertino, Annalisa Maria Ardiri, Giuseppe Stefano Calvagno, et al.
Digestive Diseases and Sciences|September 9, 2011
Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitisMichele Malaguarnera, Marco Vacante, Tijana Antic, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 20, 2011
The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirinMichele Malaguarnera, Marco Vacante, Gaetano Bertino, et al.
Archives of Gerontology and Geriatrics|June 24, 2010
Losartan vs. amlodipine treatment in elderly oncologic hypertensive patients: a randomized clinical trialMassimo Motta, Cristina Russo, Marco Vacante, et al.
Pageof 8